# The Bleeding With Antithrombotic Therapy Study 2

> **NCT02889653** · — · COMPLETED · sponsor: **National Cerebral and Cardiovascular Center, Japan** · enrollment: 5306 (actual)

## Conditions studied

- Cerebrovascular and Cardiovascular Diseases

## Interventions

- **DRUG:** Any oral antithrombotics (antiplatelets or anticoagulants)

## Key facts

- **NCT ID:** NCT02889653
- **Lead sponsor:** National Cerebral and Cardiovascular Center, Japan
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2020-03
- **Final completion:** 2021-03
- **Target enrollment:** 5306 (ACTUAL)
- **Last updated:** 2023-11-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02889653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02889653, "The Bleeding With Antithrombotic Therapy Study 2". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02889653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*